Mesoblast Limited Dividend 2022

Mesoblast Limited (MSB) is an Australian company engaging in the development of biologic products for regenerative medicine. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp cells and Adipose cells. Its intellectual property covers applications in key markets including the United States, Europe, Japan and China.

Mesoblast Limited operators in Health Care sector and under industry of Biotechnology. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

MSB Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found